The US Department of Justice (DOJ) has announced a $9.8m settlement with Illumina, known for its work in DNA sequencing and other technologies, citing allegations that the company sold genomic-sequencing systems with software vulnerabilities to federal agencies for multiple years.
The case against the biotech company specializing in
Free Trial
Register for free to keep reading.
To continue reading this article and unlock full access to GRIP, register now. You’ll enjoy free access to all content until our subscription service launches in early 2026.
- Unlimited access to industry insights
- Stay on top of key rules and regulatory changes with our Rules Navigator
- Ad-free experience with no distractions
- Regular podcasts from trusted external experts
- Fresh compliance and regulatory content every day
